Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ
Market Cap
$126.19M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
566 of 951
Rank in Industry
309 of 544
Largest Insider Buys in Sector
BDTX Stock Price History Chart
BDTX Stock Performance
About Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Black Diamond Therapeutics, Inc.
Over the last 12 months, insiders at Black Diamond Therapeutics, Inc. have bought $0 and sold $1.4M worth of Black Diamond Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Black Diamond Therapeutics, Inc. have bought $60M and sold $10.24M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 400,000 shares for transaction amount of $934,080 was made by BIOTECH GROWTH N V (10 percent owner) on 2023‑10‑17.
List of Insider Buy and Sell Transactions, Black Diamond Therapeutics, Inc.
| 2024-08-28 | Sale | 10 percent owner | 221,600 0.3894% | $6.32 | $1.4M | -50.86% | ||
| 2023-10-17 | 10 percent owner | 400,000 0.7707% | $2.34 | $934,080 | +99.57% | |||
| 2023-07-05 | director | 1M 2.8199% | $5.00 | $5M | -26.34% | |||
| 2023-07-05 | director | 935,850 2.639% | $5.00 | $4.68M | -26.34% | |||
| 2023-06-30 | 10 percent owner | 1M 2.7138% | $5.00 | $5M | -28.71% | |||
| 2023-06-27 | Sale | SEE REMARKS | 25,000 0.0743% | $6.70 | $167,500 | -41.59% | ||
| 2023-06-27 | 10 percent owner | 1.74M 4.2378% | $5.49 | $9.56M | -41.59% | |||
| 2022-12-22 | SEE REMARKS | 36,363 0.0972% | $1.28 | $46,596 | +73.11% | |||
| 2022-12-21 | SEE REMARKS | 20,000 0.0546% | $1.29 | $25,770 | +74.62% | |||
| 2022-10-31 | director | 99,801 0.268% | $2.25 | $224,912 | -6.28% | |||
| 2022-10-28 | director | 172,974 0.4696% | $2.18 | $376,962 | -1.81% | |||
| 2022-10-27 | director | 191,678 0.5124% | $1.87 | $359,224 | +12.69% | |||
| 2022-10-21 | director | 87,850 0.2313% | $1.51 | $132,750 | +37.97% | |||
| 2022-10-20 | director | 53,734 0.144% | $1.42 | $76,345 | +48.97% | |||
| 2022-10-19 | director | 77,689 0.2096% | $1.32 | $102,775 | +61.48% | |||
| 2022-06-29 | SEE REMARKS | 25,000 0.0681% | $2.44 | $61,018 | -16.60% | |||
| 2022-04-27 | 150,000 0.4047% | $2.66 | $399,480 | -22.79% | ||||
| 2022-04-18 | 150,000 0.4099% | $3.29 | $493,935 | -35.24% | ||||
| 2022-04-12 | 150,000 0.4078% | $3.42 | $513,600 | -37.46% | ||||
| 2021-05-12 | Sale | See Remarks | 4,078 0.0111% | $27.42 | $111,805 | -72.50% |
Insider Historical Profitability
<0.0001%
| Versant Venture Capital VI, L.P. | 10 percent owner | 3726341 6.5854% | $2.23 | 1 | 28 | <0.0001% |
| BIOTECH GROWTH N V | 10 percent owner | 8517839 15.0531% | $2.23 | 9 | 0 | +10.34% |
| Behbahani Ali | director | 4448757 7.8621% | $2.23 | 2 | 0 | <0.0001% |
| BB BIOTECH AG | 4438402 7.8438% | $2.23 | 3 | 0 | <0.0001% | |
| RA CAPITAL MANAGEMENT, L.P. | director | 3213828 5.6796% | $2.23 | 1 | 0 | <0.0001% |
| Shah Rajeev M. | director | 1924164 3.4005% | $2.23 | 1 | 0 | <0.0001% |
| Bolzon Bradley J PhD | 874099 1.5448% | $2.23 | 1 | 27 | <0.0001% | |
| Flynn James E | 10 percent owner | 778790 1.3763% | $2.23 | 1 | 0 | <0.0001% |
| Epstein David M. | SEE REMARKS | 671423 1.1866% | $2.23 | 0 | 5 | |
| Ni Fang | SEE REMARKS | 125389 0.2216% | $2.23 | 3 | 0 | +43.71% |
| Hatzis-Schoch Brent | See Remarks | 8400 0.0148% | $2.23 | 1 | 9 | <0.0001% |
| INGRAM ROBERT ALEXANDER | director | 5000 0.0088% | $2.23 | 1 | 0 | <0.0001% |
| Roberts Christopher D. | Chief Scientific Officer | 3200 0.0057% | $2.23 | 0 | 10 | |
| Leggett Thomas | Chief Financial Officer | 0 0% | $2.23 | 0 | 5 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Bellevue Group | $43.19M | 15.14 | 8.52M | -0.21% | -$91,260.00 | 0.66 | |
| T Rowe Price Investment Management Inc | $34.1M | 11.96 | 6.73M | +71.22% | +$14.18M | 0.02 | |
| Nea Management Company Llc | $22.56M | 7.91 | 4.45M | 0% | +$0 | 0.11 | |
| RA Capital Management, L.P. | $17.88M | 6.27 | 3.53M | 0% | +$0 | 0.02 | |
| The Vanguard Group | $9.66M | 3.39 | 1.91M | -2.15% | -$211,890.51 | <0.0001 | |
| Tang Capital Management, LLC | $8.13M | 2.85 | 1.6M | -11.09% | -$1.01M | 0.03 | |
| BlackRock | $7M | 2.45 | 1.38M | +2.26% | +$154,508.24 | <0.0001 | |
| Artal Group S A | $5.31M | 1.86 | 1.05M | -48.86% | -$5.07M | 0.02 | |
| Laurion Capital Management LP | $4.45M | 1.56 | 878,286 | New | +$4.45M | 0.03 | |
| Kennedy Capital Management Inc | $3.64M | 1.28 | 717,183 | -3.2% | -$120,250.27 | 0.08 | |
| Blue Owl Capital Holdings Lp | $3.52M | 1.24 | 695,000 | 0% | +$0 | 0.3 | |
| Driehaus Capital Management LLC | $3.07M | 1.08 | 605,901 | -13.07% | -$461,714.75 | 0.03 | |
| Millennium Management LLC | $2.77M | 0.97 | 546,237 | +348.44% | +$2.15M | <0.01 | |
| Boxer Capital, LLC | $2.57M | 0.9 | 506,000 | 0% | +$0 | 0.05 | |
| Susquehanna International Group | $2.15M | 0.75 | 423,923 | +92.42% | +$1.03M | <0.01 | |
| Geode Capital Management | $1.94M | 0.68 | 382,613 | +9.18% | +$163,125.79 | <0.0001 | |
| Two Sigma | $1.82M | 0.64 | 358,064 | -2.51% | -$46,791.02 | <0.01 | |
| Goldman Sachs | $1.69M | 0.59 | 333,248 | +624.69% | +$1.46M | <0.0001 | |
| Verition Fund Management Llc | $1.67M | 0.59 | 328,906 | -78.84% | -$6.21M | 0.02 | |
| Connor Clark & Lunn Investment Management Ltd | $1.59M | 0.56 | 314,502 | New | +$1.59M | <0.01 | |
| Ubs Oconnor Llc | $1.3M | 0.46 | 257,000 | New | +$1.3M | 0.06 | |
| Jane Street Capital | $1.27M | 0.45 | 250,555 | +353.33% | +$990,095.07 | <0.01 | |
| Renaissance Technologies | $1.08M | 0.38 | 212,600 | -52.8% | -$1.21M | <0.01 | |
| Bridgeway Capital Management | $877,110.00 | 0.31 | 173,000 | -9.9% | -$96,330.00 | 0.01 | |
| Qube Research & Technologies | $875,229.00 | 0.31 | 172,629 | +269.58% | +$638,409.31 | <0.01 | |
| Squarepoint Ops LLC | $868,876.00 | 0.31 | 171,376 | +18.31% | +$134,476.63 | <0.01 | |
| Acadian Asset Management | $864,000.00 | 0.3 | 170,510 | +13.75% | +$104,464.40 | <0.01 | |
| Barclays | $848,000.00 | 0.3 | 167,246 | 0% | +$0 | <0.0001 | |
| Wellington Management Company | $840,028.00 | 0.3 | 165,686 | New | +$840,028.00 | <0.0001 | |
| Stifel | $751,881.00 | 0.26 | 148,300 | +32.77% | +$185,562.00 | <0.01 | |
| Newtyn Management | $633,750.00 | 0.22 | 125,000 | -55.36% | -$785,850.00 | 0.14 | |
| Hrt Financial Llc | $634,000.00 | 0.22 | 125,094 | New | +$634,000.00 | <0.01 | |
| Man Group Plc | $605,662.00 | 0.21 | 119,460 | New | +$605,662.00 | <0.01 | |
| State Street | $593,616.00 | 0.21 | 117,084 | +1.12% | +$6,591.00 | <0.0001 | |
| ExodusPoint Capital Management, LP | $586,000.00 | 0.21 | 115,576 | +295.32% | +$437,765.97 | 0.01 | |
| Citigroup | $570,127.00 | 0.2 | 112,451 | +107.77% | +$295,718.11 | <0.0001 | |
| Dimensional Fund Advisors | $566,147.00 | 0.2 | 111,666 | +0.95% | +$5,343.78 | <0.0001 | |
| Northern Trust | $527,442.00 | 0.19 | 104,032 | -5.16% | -$28,680.98 | <0.0001 | |
| Foundations Investment Advisors | $489,255.00 | 0.17 | 96,500 | New | +$489,255.00 | 0.02 | |
| Two Sigma Advisers LP | $488,241.00 | 0.17 | 96,300 | -6.41% | -$33,462.00 | <0.01 | |
| Marathon Trading Investment Management Llc | $478,608.00 | 0.17 | 94,400 | New | +$478,608.00 | 0.1 | |
| Td Asset Management Inc | $359,199.00 | 0.13 | 70,848 | New | +$359,199.00 | <0.0001 | |
| Castleview Partners LLC | $323,800.00 | 0.11 | 63,866 | New | +$323,800.00 | 0.22 | |
| Morgan Stanley | $298,613.00 | 0.11 | 58,898 | +397.83% | +$238,629.80 | <0.0001 | |
| Cornercap Investment Counsel Inc | $246,549.00 | 0.09 | 48,629 | -41.26% | -$173,165.83 | 0.04 | |
| Cubist Systematic Strategies | $221,554.00 | 0.08 | 43,699 | +192.93% | +$145,919.72 | <0.01 | |
| Jump Financial Llc | $195,033.00 | 0.07 | 38,468 | -1.08% | -$2,129.40 | <0.01 | |
| Point72 Asia Singapore Pte Ltd | $188,325.00 | 0.07 | 37,145 | New | +$188,325.00 | 0.02 | |
| Balyasny Asset Management Llc | $177,049.00 | 0.06 | 34,921 | New | +$177,049.00 | <0.0001 | |
| Pale Fire Capital Se | $170,844.00 | 0.06 | 33,697 | -34.06% | -$88,233.32 | <0.01 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.